Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment
暂无分享，去创建一个
T. Miyagishima | N. Sakamoto | S. Ohnishi | M. Natsuizaka | Masaru Baba | T. Meguro | Yoshiya Yamamoto | T. Sho | K. Morikawa | Koji Ogawa | G. Suda | M. Kimura | O. Maehara | K. Terashita | M. Ohara | Yoshimasa Tokuchi | Ren Yamada | Kazuharu Suzuki | M. Nakai | Sonoe Yoshida | N. Kawagishi | Zijian Yang | Ken Furuya | J. Ito | T. Izumi | Shunichi Hosoda | Akinori Kubo | A. Nakamura | Takashi Kitagataya | Kenichi Morikawa | Masato Nakai | Osamu Maehara | Takaaki Izumi | Masatsugu Ohara | Mitsuteru Natsuizaka